Stock Price Quote

SMS LIFESCIENCES INDIA LTD.

NSE : SMSLIFEBSE : 540679ISIN CODE : INE320X01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE1209.90-0.1 (-0.01 %)
PREV CLOSE ( ) 1210.00
OPEN PRICE ( ) 1284.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1296
TODAY'S LOW / HIGH ( )1170.00 1331.00
52 WK LOW / HIGH ( )630.75 1747.85
NSE1212.259.55 (+0.79 %)
PREV CLOSE( ) 1202.70
OPEN PRICE ( ) 1299.95
BID PRICE (QTY) 1212.25 (1)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5178
TODAY'S LOW / HIGH( ) 1162.10 1322.95
52 WK LOW / HIGH ( )626.45 1749.65
1D 1M 3M 1Y 3Y 5Y
JavaScript chart by amCharts 3.4.2Show all

STOCK SUMMARY

Incorporation Year : 31-05 2006
Management Info
- Chairman TVVSN Murthy - Managing Director
Registered Office

Address Plot No 19 – I I I, Road No 71,Opp. Bharatiya Vidya Bhavan Public School,Jubilee Hills,
Hyderabad,
Telangana-500096

Phone 040-66288888

Email info@smslife.in

Website www.smslife.in

Registrars Details
Aarthi Consultants Pvt Ltd
1-2-285 ,Domalaguda,,Hyderabad
Listing : BSE, NSE

NEWS

05Apr SMS Lifesciences India informs about d
SMS Lifesciences India has confirmed that the following persons whose re..
05Apr SMS Lifesciences India informs about a
SMS Lifesciences India has enclosed the annual disclosure received from..
20Mar SMS Lifesciences India informs about d
SMS Lifesciences India has informed that it enclosed the disclosure unde..
20Mar SMS Lifesciences India informs about d
SMS Lifesciences India has informed that the exchange has received the d..
04Mar Clarification (Credit Ratings)
Care ratings Limited through its letter dated 28.02.2025 has independent..

Financials

in Millions
QTR Dec 24 ANNUAL 24
Net Profit62.2800000000001130.65
Gross Profit 86.1000000000001 191.12
Operating Profit 131.3382.68
Net Sales 828.763000.02

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Torrent Pharma (BSE)
peergroup  3284.75 (1.08%)
M.Cap ( in Cr)111170.87
Mankind Pharma (BSE)
peergroup  2450.40 (0.93%)
M.Cap ( in Cr)101098.24
Bal Pharma (BSE)
peergroup  121.70 (11.61%)
M.Cap ( in Cr)193.81
Sanofi India (BSE)
peergroup  6011.35 (0.19%)
M.Cap ( in Cr)13844.51
Source Natural Foods (BSE)
peergroup  193.95 (3.11%)
M.Cap ( in Cr)124.84

Shareholding Pattern

PROMOTERS 71.41%
NON-INSTITUTION 28.59%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About SMS Lifesciences India Ltd.

SMS Lifesciences India Ltd. was incorporated in the year 2006. Its today's share price is 1209.9. Its current market capitalisation stands at Rs 365.79 Cr. In the latest quarter, company has reported Gross Sales of Rs. 3287.48 Cr and Total Income of Rs.3038.38 Cr. The company's management includes Trupti Ranjan Mohanty, Srinivas Samavedam, Mannam Malakondaiah, P Sarath Kumar, Sudeepthi Gopineedi, T V Praveen, TVVSN Murthy.

It is listed on the BSE with a BSE Code of 540679 , NSE with an NSE Symbol of SMSLIFE and ISIN of INE320X01016. It's Registered office is at Plot No 19 – I I I, Road No 71,Opp. Bharatiya Vidya Bhavan Public School,Jubilee HillsHyderabad-500096, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Rambabu & Co

1.NSE exchange is Stopping the facility of Stop-Loss Market (SL-M) orders In option trade from 27th Sept 2021 to avoid freak trades and reduce its impact significantly. 2. Introduction of T+1 rolling settlement on optional basis. Stock Exchange may choose to offer T+1 settlement cycle. There shall be no netting between T+1 and T+2 settlements. Circular provisions come into force with effect from Jan: @SEBI_India 3. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. 4. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 5. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Do not share sensitive information like User ID, Password, OTP, etc., with anyone. Regards, Nirmal Bang.
1.NSE exchange is Stopping the facility of Stop-Loss Market (SL-M) orders In option trade from 27th Sept 2021 to avoid freak trades and reduce its impact significantly. 2. Introduction of T+1 rolling settlement on optional basis. Stock Exchange may choose to offer T+1 settlement cycle. There shall be no netting between T+1 and T+2 settlements. Circular provisions come into force with effect from Jan: @SEBI_India 3. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. 4. Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 5. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Do not share sensitive information like User ID, Password, OTP, etc., with anyone. Regards, Nirmal Bang.

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.
Close X
OPEN

DEMAT ACCOUNT

AND START YOUR

INVESTMENT

JOURNEY WITH US
(You will receive a Call & SMS from our end)
Popup-Character

Disclaimer: NIRMAL BANG SECURITIES PVT LTD: Investment in Securities market are subject to market risks. Read all the related documents carefully before investing. Please read the Do’s and Don’ts prescribed by the Commodity Exchange before trading. We do not offer PMS Service for the Commodity segment. Opening of account will not guarantee allotment of shares in IPO. Investors are requested to do their own due diligence before investing in any IPO. The securities quoted are exemplary and are not recommendatory. BSE (Member ID- 498): INB011072759, INF011072759, Exchange Registered Member in CDS; NSE MEMEBR ID- 09391): INB230939139, INF230939139, INE230939139; MSEI Member ID-1067): INB260939138, INF260939138, INE260939139: Single Registration No. INZ000202536, PMS Registration No: INP000002981; Research Analyst Registration No: INH000001766; NSDL/ CDSL: IN-DP-CDSL 37-99; Exchange Member ID: MCX - 56460, NCDEX - 1268, ICEX – 2073. Regd. Office: B-2, 301/302, 3rd Floor, Marathon Innova, Off Ganpatrao Kadam Marg, Lower Parel (W), Mumbai - 400013. Tel: 62738000/01; Fax: 62738010 | *NIRMAL BANG NIVESHALAYA PVT LTD: ARN – 111233, Mutual Fund Distributor. Mutual Fund Investments are subject to market risks. Please read the offer documents carefully before Investing.” Regd. Office: B - 201, Khandelwal House, Poddar Road, Near Poddar Park, Malad (East). Mumbai – 400097. | **NIRMAL BANG INSURANCE BROKING PVT LTD: IRDAI Registration No: 795 and Registration Code For the Insurance Broker: IRDAI/DB889/2021. Insurance is the subject matter of the solicitation. For more details on policy terms, conditions, exclusions, limitations, please refer/read policy brochure carefully before concluding sale.